Replication of human papillomavirus (HPV) DNA requires the viral proteins E1 and E2. Amino acid similarities to SV40 large-T antigen had suggested that E1 is a DNA helicase/ATPase involved in initiating viral DNA replication, and this has recently been shown for bovine papillomavirus type 1 (BPV-1) E1 protein.
INTRODUCTION
Human papillomavimses (HPVs) are small DNA viruses which infect epithelial cells inducing the formation of benign tumors or papillomas. HPVs cause a range of disease from benign hand warts, to genital warts, and life-threatening laryngeal papillomas. Since there are no effective anti-viral treatments, current therapy relies mainly on removal or destruction of infected tissue and must often be repeated. The HPV types associated with anogenital lesions can be divided into two groups: 'low-risk' HPVs, such as HPV-6b and HPV-11, which are associated with genital warts, and the 'high-risk' HPVs, such as HPV-16 or HPV-18, which are associated with lesions that can progress to malignancy. There is now compelling evidence from both epidemiological and biological studies to suggest that high-risk HPVs are involved in anogenital cancers, particularly cervical cancer (reviewed in 1).
HPVs show extreme tissue specificity for epithelial keratinocytes, and their life-cycle is closely coupled to keratinocyte differentiation. Thus in wart tissue the viral genome is maintained as a low-copy-number episome in the proliferating basal epithelial cells. As the infected cells undergo progressive differentiation, episome copy number and viral gene expression increase, until late gene expression and virion assembly occur in the terminally-differentiated cells at the surface. Due to the inability to propagate HPV in tissue culture, the inability to analyse it genetically, and the lack of suitable HPV animal models, much of our knowledge of HPV molecular biology has come from studies with surrogate viruses, eg. bovine papillomavirus type 1 (BPV-1), or from the study of isolated HPV genes.
In BPV-1, early genetic evidence had indicated that the El and E2 genes are essential for episome maintenance (reviewed in 2). Amino acid similarities suggested that El, like SV40 large-T antigen, may be a DNA helicase/ATPase involved in initiating viral DNA replication (3) . Subsequently, BPV-1 El protein was shown to be a nuclear 68-72 kD ATP-binding phosphoprotein (4, 5, 6) . A mutation in El (Pro-434 to Ser), analogous to that in the SV40 large-T antigen mutant tsA209 that impairs ATPbinding, renders BPV-1 defective for DNA replication and abolishes ATP-binding by El (6) . More recently, it was established that El and E2 are necessary and sufficient for the transient replication of plasmids containing the BPV-1 replication origin (ori) in transfected cells (7) . The ori maps to a 60 bp fragment centered on a unique Hpal site in BPV-1 DNA and contains binding sites for El and E2 proteins (8, 9) . El and E2 also bind each other directly, and a major role of E2 in replication may be its ability to strengthen die El -ori interaction (4, 10, 11). Yang et al. (12) have demonstrated the replication of oncontaining plasmids in cell-free extracts in the presence of BPV-1 El and E2 proteins. Recently, BPV-1 El has been purified and shown to have the predicted ATPase and DNA helicase activities (13, 14) .
Until recently little was known about HPV DNA replication. However, transient replication experiments have demonstrated the essential roles of El and E2 for a number of HPV types (15, 16, 17) . Although HPV and BPV-1 El clearly have analogous functions, there are significant sequence differences, particularly in the N-terminal region (18) , which would suggest that they are not identical. However, in vitro biochemical studies of HPV El have been hampered by the difficulty in producing purified protein; pure protein is particularly important in the analysis of ATPase activity, since cellular ATPases are ubiquitous. Bream etal. (19) expressed HPV-11 El and E2 using the baculovirus system, demonstrated that the unpurified proteins bind to each other, and reported that El immunoprecipitated from cell extracts had ATPase activity several-fold above control. In this study we have produced sufficient El protein from HPV type 6b, as a fusion to maltose-binding protein (MBP-E1) in E.coli, to demonstrate DNA helicase and ATPase activity in purified preparations. As further confirmation that ATPase and DNA helicase activity are not due to contaminating E.coli enzymes, we have shown that a fusion protein containing an amino acid change predicted to inactivate ATP-binding has impaired ATPase and DNA helicase activity. Finally, MBP-E1 expressed in E.coli shows a susceptibility to cleavage at a site within a region of El predicted to be an inter-domain linker, generating a stable 58 kD C-terminal domain fragment.
MATERIALS AND METHODS

Construction of recombinant plasmids
The oligonucleotides ACGTACGGATCCACGATGGCGG-ACGATTCAGGTAC and ACGTGAATTCTTAGAACTCCTC-TAAAGTTCTAACAACTGTTCCTGG were used in a polymerase chain reaction (Perkin-Elmer Cetus kit) to amplify the El gene from an HPV-6b genomic clone (20) , with a 5' BamHI site and 3' EcoBI sites. The 3' primer contained additional codons for the C-terminal amino acids Glu-Glu-Phe, since these bind the tubulin monoclonal antibody YLl/2 and may be used for affinity purification (21) . Since the El gene contains an internal EcdBl site, the 2 kb PCR product was digested with BamHI and HindUl to isolate the 5' 1458 bp fragment and with EcoRl and HindUl to isolate the 3' 484 bp fragment. These two fragments were joined with pIC-20H (22) , digested with BamHI and EcdRI, to generate the plasmid pIC-El. In order to eliminate the possibility of base changes from PCR, the central 1430 bp PpuMl to Pad fragment was replaced with the equivalent fragment from the original HPV-6b DNA, and the authenticity of the 5' and 3' ends of the gene was confirmed by nucleotide sequence analysis.
As a source of a gene encoding El protein without the GluGlu-Phe tag, the 1980 bp Fspl-Scal fragment from HPV-6b DNA was cloned into the Smal site of pUC18. Recombinant plasmids containing El in the same orientation as lacZ' were designated pUC18-Ela.
For expression of mature El with the Glu-Glu-Phe tag in E.coli, under control of the tac promoter, the BamHI-Xhol fragment from pIC-El was ligated between the BamHI and Sail sites of pTrc99A (Pharmacia), to generate pTrc-El. An expression vector for El fused to the C-terminus of glutathione S-transferase (GST), pGEX-El, was constructed by joining the 1458 bp BamHl-Hindm and 484 bp HindUI-EcoKI fragments from pIC-El to pGEX-2T (Pharmacia) digested with BamHI and In contrast to the plasmids described above, expression vectors for El containing an N-terminal His 6 affinity tag (pRSET-El) and El fused to the C-terminus of maltose-binding protein (pMAL-El), did not contain the C-terminal Glu-Glu-Phe tag. pRSET-El and pMAL-El were constructed by joining the 1677 bp BamHI-Pad fragment from pGEX-El and the 306 bp Pad-Sad fragment from pUC18-Ela to BamHI and Xholdigested pRSETA (Invitrogen) or BamHI and Sa/I-digested pMAL-c2 (New England Biolabs), respectively.
pMAL-ElA contained a mutation leading to the amino acid substitution Pro-479 to Ser (numbering from the initiating Met of El). It was constructed by ligating a pair of synthetic oligonucleotides containing the mutation (CCT to TCT) between the £coRI and P/ZMI sites of El in pMAL-El; the plasmid was confirmed by nucleotide sequence analysis.
Induction and purification of El proteins
pRSET-El was introduced into E.coli host strains BL21(DE3) and HMS174(DE3) or the equivalent strains containing pLysS, and induced as described previously (23) . pMAL-El and pMAL-E1A were introduced into the E.coli strain MC1061. Cultures were grown in L broth containing carbenicillin (50 /tg/mi), and cells from starter cultures were pelletted and resuspended in fresh medium to reduce levels of secreted /3-lactamase. 4-litre cultures were grown at 37°C to an Agso of 0.8-1.0 then induced at 25 °C for 2 h by addition of isopropyl 0-D-thiogalactoside (IPTG) to 1 mM. Induced cells were harvested by centrifugation at 4°C and resuspended in 80 ml of ice-cold amylose column buffer (10 mM tris HC1 pH 7.4, 200 mM NaCl, lmM EDTA, 1 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride, 2 /ig/ml leupeptin, 1 jtg/ml pepstatin, 2 /ig/ml antipain and 2 /ig/ml aprotinin). The cells were lysed by three or four rounds of sonication (30 s of 2.5 s pulses with 2.5 s rests) with cooling on ice. Insoluble protein and membranes were removed from the lysate by ultracentrifugation for 1 h at 40,000 rpm in a Beckman 70Ti rotor (100,000 g), and the extract was loaded onto a 5-ml amylose resin column (New England Biolabs). The column was washed with 100 ml of column buffer + 5 % glycerol + protease inhibitors, and maltose-binding protein (MBP)-fusions eluted with wash buffer containing 10 mM maltose. A 4-litre culture yielded up to 0.9 mg of eluted protein of which typically 25% was full-length MBP-E1.
In order to purify MBP-E1 further, maltose-eluates from a single preparation were concentrated to 200 pi by ultrafiltration using Centricon 30 filters (Amicon). The concentrate was loaded onto a 30-ml Superose 12 column, in a Pharmacia FPLC system, pre-equilibrated with 10 mM sodium phosphate pH 7.4, 0.3 M NaCl at room temperature, and eluates were collected on ice.
Protein analysis Proteins were analysed by electrophoresis in 7.5% or 10% SDSpolyacrylamide gels followed by staining with Coomassie blue or Western blotting. Soluble proteins could be distinguished from insoluble ones by centrifugation for 15 min at 12000 g at 4°C. For Western blotting, proteins were transferred to Immobilon P membrane (Millipore). The El peptide antiserum was raised in rabbits against the HPV-11 El peptide TTQPKKVKRRLF-ETRELTDSGYGYS (amino acids 116-140; reference 19); it cross-reacted with HPV-6b El protein. Antiserum to MBP was from New England Biolabs. Detection was with alkaline phosphatase IgG conjugates (Sigma) and BCIP/NBT chromogenic reagents (Sigma).
Factor Xa cleavage of MBP-fusion proteins was carried out according to the manufacturer's instructions (New England Biolabs) at a Factor Xa to protein ratio of 1/50 for 2 to 24 hours at room temperature.
For N-terminal sequence analysis, proteins were transferred to Immobilon P, bands identified by brief staining in 0.005 % Coomassie blue and the bands excised. This method was also used to locate stained polypeptide bands during Western blotting. The membranes were destained in methanol and analysed in an Applied Biosystems ABI477A pulse liquid sequencer using the Normal-1 program.
ATPase and DNA helicase assays ATPase activity in protein samples was detected by the release of 32 P-phosphate from [7- 32 P]ATP. Reactions were in 20 /il 50 mM tris HC1 pH 8.0, 100 mM NaCl, 10 mM MgCl 2 , 1 mM dithiothreitol, 0.5 /M ATP and contained 0.1 /tCi [7- 32 P]ATP (Amersham, 3000 Ci/mmol) each. After incubation at 37°C for 1-2 h, 1 /il was spotted onto a polyethyleneimine (PEI) thinlayer chromatography plate, allowed to dry, and the plate developed with 0.375 M potassium phosphate pH 3.5. Plates were then subjected to autoradiography with Kodak XAR-5 film for 1 h.
DNA helicase activity was detected by the release of labelled oligonucleotide annealed to M13 single-stranded DNA (ssDNA). The substrate was prepared by annealing excess Ml3-40 sequencing primer (GTTTTCCCAGTCACGAC) to 1 /ig M13 mpl8 ssDNA, then 3'-end labelling the hybrid by extension with dTTP, dGTP and [a-32 P]ATP (Amersham, 3000 Ci/mmol) using Klenow fragment. Excess labelled nucleotide was removed by gel filtration (NICK columns, Pharmacia), and the substrate eluted in 400 /il 10 mM tris HC1 pH7.4,0.1 mM EDTA. Helicase assays were carried out using 10 /il of substrate and up to 30 fil of protein in a final volume of 50 /il containing 20 mM tris HC1 pH 7.4, 10 mM MgCl 2 , 0.5 mM dithiothreitol, 2 mM ATP, 0.1 mg/ml bovine serum albumin, incubated at 37°C for 2-3 h. Reactions were stopped by addition of 5 /il 3.3% SDS and 5 /il 0.5 M EDTA; samples were loaded onto 20% polyacrylamide gels (non-denaturing) which were run at 200 V for 3-4 h, fixed and autoradiographed wet at room temperature. Helicase activity was detected by release of labelled 23-base oligonucleotide.
Computer predictions
Predictions of physico-chemical parameters from the amino acid sequence of El were based on published methods (24) . Three parameters, location of core or non-core residues, coil prediction by three-state secondary structure methods, and hydrophilicity, are selected for illustration.
RESULTS
Expression of El and MBP-E1 fusion proteins in E.coli
Preliminary experiments attempting to produce mature HPV-6b El protein in E.coli, using the vector pTrc-El, were unsuccessful due to the toxicity of the product. We were able to produce El containing an N-terminal His 6 tag using the T7 expression vector pRSET-El, but the product (approx. 80 kD) was insoluble and could not be extracted in native form for purification (Fig. 1 A Soluble protein extract from a 4-litre induction was applied to a 5-ml amylose resin column. The column was washed with 100 ml of column buffer, and elution was with 10 mM maltose in 1-ml fractions. 30 /J of selected fractions were separated on a 7.5% SDS-polyacrylamide gel which was stained with Coomassie blue. Lane 1, soluble protein applied to column (50 /ig); lanes 2-7, maltoseeluates (fractions 6-11 , respectively lane 2). However, an immunoreactive product of approximately 58 kD was seen in the soluble protein fraction (Fig. 1A, lane 3) . We were also able to produce intact El to levels of 2-6% of cell protein using the baculovirus system but only a very small proportion of this was soluble (data not shown). Finally, El could be produced as a fusion protein to glutathione S-transferase (GSTEl) or to maltose-binding protein (MBP-E1) with reduced toxic effects on the host cells; due to a persistent degradation problem with GST-El, we have concentrated on the purification and biochemical activities of MBP-E1. The plasmid pMAL-El encodes a polypeptide containing MBP (40 kD), followed by an Asn 10 linker, Factor Xa cleavage site, and mature El (73 kD). E.coli cells containing the plasmid gave rise upon induction to a polypeptide of the expected size (116 kD) which reacted with both MBP and El peptide antisera. Extracts from 4-litre inductions were prepared and subjected to affinity purification using amylose resin. Upon elution with maltose, full-length MBP-E1 (116 kD) was recovered, along with major polypeptides of 63 kD and 40 kD, detectable by Coomassie blue staining in SDS-polyacrylamide gels (Fig. IB, lane 2) . The proportions of these proteins varied in different preparations. They all reacted with MBP antiserum in Western blots (Fig. IB,  lane 4) . MBP-E1 (116 kD) and a minor band of approximately 58 kD reacted with El antiserum (Fig. IB, lane 6) .
N-terminal sequence analysis of the 116 kD, 63 kD and 40 kD species isolated from gels showed that all had the same N-terminus as MBP (Met-Lys-De-Glu-Glu-Gly-Lys-Leu...). This indicates that the 40 kD protein was generated by cleavage at the junction of MBP and El, and the 63 kD protein by cleavage within El (approximately 20 kD from its N-terminus). Maltoseeluates also contained a number of minor bands (40-63 kD) which reacted with antiserum to MBP (Fig. IB, lane 4) . We conclude that the N-terminal 20 kD region of El contains several sites susceptible to proteolytic cleavage in E.coli, and that amylose affinity chromatography separates a nested set of MBP fusion proteins ending in this region, in addition to full-length MBP-E1.
We were not able to isolate sufficient amounts of the 58 kD protein to determine the N-terminus, but the fact that it did not react with MBP antiserum suggested that it is derived entirely from El. The observation that a 58 kD polypeptide accumulated in E.coli cells containing either pRSET-El or pMAL-El suggests that this represents a stable C-terminal region of El.
These conclusions, summarised in Fig. 1C , were consistent with the results of Factor Xa cleavage. Full-length MBP-E1, the 63 kD fragment, and most of the minor bands were cleaved, while the 58 kD fragment remained intact (Fig. IB, lanes 3, 5, and 7 ). An MBP band of 43 kD was generated, in addition to the 40 kD MBP band present before digestion. Determination of the exact masses of these species by electrospray mass spectroscopy (data not shown) indicated that the 40 kD protein had been generated by clipping between a Ser residue and the Asnio linker, while the 43 kd protein was the expected Factor Xa cleavage product. Unfortunately, only very small amounts of mature El were generated by Factor Xa cleavage (Fig. IB, lane 7) .
MBP-E1 has ATPase and DNA helicase activities
Since MBP-E1 purified by amylose resin affinity chromatography was relatively pure, the only detectable contaminants being related degradation products ( Fig.2A) , we assayed column fractions for ATPase and DNA helicase activities. High-level ATPase activity, representing E.coli ATPases, was found in the flow-through and first wash fractions, but this dropped to undetectable levels in later wash fractions (Fig.2B ). Upon elution with maltose, a peak of ATPase activity was seen in fractions 7 and 8, corresponding to the fractions containing MBP-El (Fig.2B) . These fractions also contained GTPase activity (data not shown).
Fractions from amylose resin chromatography were also assayed for DNA helicase activity (Fig.2C) . DNA unwinding was detected by the release of a 3'-32 P-labelled 23-mer from M13 mpl8 ssDNA which was then separated in non-denaturing gels. DNA helicase activity was seen, in prolonged incubations with > 5 fig of protein, mainly in fractions 7 and 8, corresponding to the MBP-El and ATPase peak. No activity was detected if ATP was omitted from the reaction.
MBP-El was further purified by FPLC gel filtration using Superose 12 resin: in buffer containing 0.3 M NaCl, two major sharp peaks were obtained (Fig.3A) . Peak A contained highly purified, full-length MBP-El (Fig.3B) . On assaying the Superose 12 fractions, almost all of the ATPase activity co-migrated with MBP-El (Fig.3C) . We could not detect significant DNA helicase activity in any of the Superose 12 fractions, presumably because the protein concentrations were much lower.
Substitution of El Pro-479 with Ser impairs MBP-El ATPase
As further confirmation that the MBP-El ATPase activity was not due to association with contaminating E.coli proteins, we Nucleic Acids Research, 1993, Vol. 21 , No. 25 5821 expressed a fusion protein (MBP-El A) containing the amino acid substitution (El Pro-479 to Ser) corresponding to the BPV-1 mutation Pro-434 to Ser, which eliminates ATP-binding and renders BPV-1 DNA unable to replicate (Fig.4A ). E.coli cells harboring the mutated plasmid, pMAL-ElA, were induced, extracts prepared and affinity-purified on amylose resin columns.
Eluates were found to contain the same pattern of polypeptides as with MBP-El, that is a full-length 116 kD product and similar degradation products (not shown). MBP-El A had no significant ATPase activity when compared to similar amounts of MBP-El under our assay conditions (Fig.4B) . The protein also lacked detectable DNA helicase activity (Fig.3C, lane 18) .
Domain structure of El
Examination of a series of aligned traces for various scaled parameters along the amino acid sequence of El revealed a qualitative difference before residue 125 and after residue 170 (Fig.5) . The C-terminal part showed a consistent density of coreforming residues (see Fig.5 ), whereas in the N-terminal part coreforming clusters were separated by appreciable surface segments. The region between these parts (residues 125 -170) was predicted to be essentially superficial, with a number of short coil segments, probably indicating a series of exposed loops or turns. This intervening region also had the most sustained high level of hydrophilicity in the entire sequence. Therefore residues 125 -170 could contain an exposed inter-domain linker, and the N-and C-terminal parts could form structurally and functionally distinct domains. The putative inter-domain linker may be accessible to proteolytic cleavage, as may be the flanking run of basic residues (120-125, KKVKRR). The pattern of proteolytic degradation seen with MBP-El in E.coli is consistent with the suggested model of El structure. Cleavage occured throughout the N-terminal 20 kD of El (Fig. 1) , 
DISCUSSION
We have demonstrated ATPase and DNA helicase activities in purified HPV El protein for the first time. Production of HPV-6b El has presented problems of toxicity to the host cells, insolubility, and instability due to proteolytic degradation in vivo. Thus El could only be produced using transient expression systems such as the T7 or baculovirus systems. Unfortunately, we were not able to extract these proteins in soluble form under non-denaturing conditions. Expression as a GST fusion in E.coli alleviated the toxicity and solubility problems, and indeed we have been able to express and purify enzymatically active GSTEl fusion protein, and mature El generated by thrombin-cleavage (unpublished). However, because of a persistent problem with proteolytic degradation, we switched to MBP-E1 fusion proteins which appear to be somewhat more stable. We have demonstrated ATPase activity that co-purifies with MBP-E1. MBP-E1, purified by amylose resin affinity chromatography and free of detectable contaminants other than degradation products, had ATPase activity. Almost all of this activity co-purified with full-length MBP-E1 upon further separation by gel filtration. This result is also consistent with the fact that none of the major degradation products found in the maltose-eluates contained large segments of El. Since cellular ATPases are ubiquitous, we sought additional, genetic evidence that the activity is associated with El. Therefore we constructed a vector, pMAL-ElA, to express a fusion protein (MBP-E1A) having the amino acid substition Pro-479 to Ser in the the nucleotide-binding motif. The equivalent mutation (Pro-427 to Leu) in SV40 renders the virus temperature-sensitive, and large-T antigen defective in ATP-binding; ATPase is impaired but the level of activity depends upon the assay conditions (25) . In BPV-1 El, the mutation causes a defect in DNA replication and ATPbinding (6) . Under our assay conditions, the altered MBP-E1 had no significant ATPase activity, providing genetic evidence to add to the biochemical evidence that HPV El is an ATPase.
MBP-E1 was also associated with DNA helicase activity. This was detected in amylose resin eluates where it was possible to use relatively large amounts of protein, but not in the gel filtration fractions. The absence of detectable helicase activity in gel filtration eluates could have been due to a number of reasons, for example dilution or denaturation of the protein. However, DNA helicase activity was ATP-dependent and was absent in MBP-E1A preparations, providing evidence that it is El-associated.
MBP-E1 ATPase activity showed no stimulation in the presence of added DNA. In contrast, Seo et al. (13) reported that BPV-1 El ATPase activity was dependent on added ss or dsDNA. A trivial explanation is that our preparations contained small amounts of DNA, sufficient to give maximum stimulation. On the other hand, this difference could reflect differences between BPV-1 and HPV. Alternatively, it could be due to a steric effect of the MBP fusion on El DNA binding which might also have a negative effect on DNA helicase activity. Unfortunately, we have not been able produce sufficient mature El from MBP-E1 using Factor Xa cleavage in order to test this possibility.
Several years ago significant sequence similarities were noted between 200 amino acids in the C-terminal half of papillomavirus El polypeptides and the large-T proteins of polyoma viruses (3). The strongest similarities were found in two blocks in the Cterminal portion of El, which correspond in SV40 and polyoma virus to sites involved in ATPase and nucleotide-binding activities. Although El is one of the most highly-conserved papillomaviral genes, a comparison of predicted polypeptide sequences from animal and human viruses shows that the Nterminal region (ie. the first 170 amino acids) is relatively divergent (18) . This suggests the possibility that N-terminus is involved in non-enzymatic functions of El that are less well conserved, such as on-binding. However, the fact that the El and E2 proteins of BPV-1 and different HPVs are interchangeable in transient replication assays argues that all El functions are qualitatively conserved.
We have carried out a detailed structure prediction analysis of El and found that the first 125 amino acids form a relatively open domain with few internal residues. In striking contrast, the C-terminal portion (approx. 450 residues, 58 kD) is predicted to be highly structured and could form a distinct domain. The region between these parts (residues 125 -170) is predicted to form a series of exposed loops or turns, and could constitute a linker between the predicted N-and C-terminal domains. These predictions appear to correspond closely with the homology data. The pattern of proteolytic degradation that we see with El proteins expressed in E.coli appears to support the structural predictions. The N-terminal 20 kD of El contains multiple minor cleavage sites and a single major cleavage site near the predicted inter-domain linker. Additionally, using two different systems, we detected stable El fragments of the correct size (58 kD) for the predicted C-terminal domain. We are attempting to purify this fragment in order to determine the precise cleavage site and enzymatic properties. It would seem likely that the C-terminal fragment indeed constitutes a functional enzymatic domain.
In summary, we have provided biochemical and genetic evidence that the HPV El protein is a DNA helicase/ATPase. The El protein of BPV-1 has previously been shown to be multifunctional, with the following activities: DNA helicase/ATPase, on-binding, binding to E2. The interchangeability of HPV and BPV proteins in transient replication assays (26) suggests that HPV El will have analogous activities. However, Bream et al. (19) have demonstrated El -E2 binding, but were only able to show El binding to the ori via El protein to E2-binding sites. Thus efficient El -ori interaction may be more dependent on E2 protein with HPV than with BPV-1. Other differences between BPV-1 and HPV may emerge. Our expression system should allow us to increase our understanding of the HPV El enzyme activity through further enzymological and genetic studies. The essential role of El in HPV replication, its high degree of conservation among different HPV types, and its enzymatic activity make it an attractive target for therapeutic intervention. The availability of suitable amounts of purified HPV enzyme will be invaluable in the search for anti-viral compounds.
